, Columnist
When an HIV Scientific Breakthrough Isn’t Enough
Trump administration funding cuts and dismantling of USAID force the focus to shift from elimination back to treatment.
A scene that could soon disappear.
Photographer: Michel Lunanga/Getty Images EuropeA landmark breakthrough in HIV prevention — a scientific feat decades in the making — received final approval from the Food and Drug Administration last month. Gilead Sciences’ lenacapavir is so effective that global health leaders had started to cautiously talk about the end of an epidemic that continues to kill more than 600,000 people each year.
We should be celebrating its arrival.